MedCity News November 19, 2024
What concrete strategies should employers pursue to control rising costs while ensuring the best member experience and clinical outcomes?
Medicine stands at a remarkable crossroads. The explosive growth in specialty drug development marks a new golden age of therapeutic innovation. In 1990 there were just 10 specialty drugs on the market. By the middle of 2024, the FDA had already approved 23 new drug therapies, with specialty medications now representing 75% of all drugs in development. These breakthroughs offer fresh hope for patients battling rare cancers, autoimmune conditions and other life-threatening diseases while transforming life for millions living with chronic conditions like Crohn’s Disease and rheumatoid arthritis.
Yet this medical renaissance comes with staggering costs. At a time when healthcare...
Today's Sponsors
Today's Sponsor